Loading resource…

Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of the ESC, and the European Society of Hypertension (ESH)
The scientific statement outlines the importance of identifying different patient phenotypes in HFpEF, emphasizing the need for tailored therapeutic approaches based on individual characteristics such as frailty and muscle wasting. It highlights the potential impact of these phenotypes on treatment responses and outcomes, advocating for further research to understand the implications for management strategies. The document is a collaborative effort from the Heart Failure Association and other European cardiovascular societies.
No account needed